Crohn disease and the gynecologic patient

Obstetrical and Gynecological Survey

Volumn 68, Issue 1, 2013, Pages 51-61

  Sides, Cleve ^a   Trinidad, Mari Charisse ^a   Heitlinger, Leo ^a   Anasti, James ^a  

^a ST LUKE S UNIVERSITY HEALTH NETWORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; BUDESONIDE; CIPROFLOXACIN; CORTICOSTEROID; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; SALAZOSULFAPYRIDINE;

ANUS DISEASE; CONTRACEPTION; CROHN DISEASE; FEMALE FERTILITY; GYNECOLOGIC CARE; GYNECOLOGIC DISEASE; HUMAN; MAINTENANCE THERAPY; MENSTRUATION; NONHUMAN; OSTEOPOROSIS; PAPANICOLAOU TEST; PATHOPHYSIOLOGY; PATIENT CARE; RECTOVAGINAL FISTULA; REVIEW; VULVOVAGINAL DISEASE;

ADULT; ANTI-BACTERIAL AGENTS; CAPSULE ENDOSCOPY; CROHN DISEASE; DISEASE MANAGEMENT; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MAGNETIC RESONANCE IMAGING; PERINEUM; PREGNANCY; PREGNANCY COMPLICATIONS; RECTOVAGINAL FISTULA; REPRODUCTIVE HEALTH; UROLOGIC DISEASES; VAGINAL DISEASES; VAGINAL SMEARS; VULVAR DISEASES; WOMEN'S HEALTH;

EID: 84872844520     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e31827b1658     Document Type: Review

References (100)

1. Loftus CG, Loftus EV Jr, Harmsen WS, et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis. 2007;13:254-261.
2. Cosnes J, Gower-Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785-1794.
3. Trachter AB, Rogers AI, Leiblum SR. Inflammatory bowel disease in women: impact on relationship and sexual health. Inflamm Bowel Dis. 2002;8:413-421.
4. Correia LM, Bonilha DQ, Ramos JD, et al. Treatment of inflammatory bowel disease and pregnancy: a review of the literature. Arq Gastroenterol. 2010;47:197-201, 2010.
5. Strober W, Fuss IJ. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology. 2011;140:1756-1767.
6. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361:2066-2078.
7. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007;369:1641-1657.
8. Deveaux PG, Kimberling J, Galandiuk S. Crohn's disease: presentation and severity compared between black patients and white patients. Dis Colon Rectum. 2005;48: 1404-1409.
9. Nikolaus S, Schreiber S. Diagnostics of inflammatory bowel disease. Gastroenterology. 2007;133:1670-1689.
10. Lewis JD. The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology. 2011;140:1817-1826.
11. Fiorino G, Bonifacio C, Peyrin-Biroulet L, et al. Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease. Inflamm Bowel Dis. 2011;17:1073-1080.
12. Sinha R, Nwokolo C, Murphy PD. Magnetic resonance imaging in Crohn's disease. BMJ. 2008;336:273-276.
13. Jensen MD, Nathan T, Rafaelsen SR, et al. Diagnostic accuracy of capsule endoscopy for small bowel Crohn's disease is superior to that of MR enterography or CT enterography. Clin Gastroenterol Hepatol. 2011;9:124-129.
14. Vucelic B. Inflammatory bowel diseases: controversies in the use of diagnostic procedures. Dig Dis. 2009;27:269-277.
15. Rutgeerts P, Vermeire S, Van Assche G. Biological therapies for inflammatory bowel diseases. Gastroenterology. 2009; 136:1182-1197.
16. Cummings JR, Keshav S, Travis SP. Medical management of Crohn's disease. BMJ. 2008;336:1062-1066.
17. Blum E, Katz JA. Postoperative therapy for Crohn's disease. Inflamm Bowel Dis. 2009;15:463-472.
18. Palamaras I, El Jabbour J, Pietropaolo N, et al. Metastatic Crohn's disease: a review. J Eur Acad Dermatol Venereol. 2008;2:1033-1043.
19. Leu S, Sun PK, Collyer J, et al. Clinical spectrum of vulva metastatic Crohn's disease. Dig Dis Sci. 2009;54:1565-1571.
20. Andreani SM, Ratnasingham K, Dang HH, et al. Crohn's disease of the vulva. Int J Surg. 2010;8:2-5.
21. Fahmy N, Kalidindi M, Khan R. Direct colo-labial Crohn's abscess mimicking bartholinitis. J Obstet Gynaecol. 2010; 30:741-742.
22. Foo WC, Papalas JA, Robboy SJ, et al. Vulvar manifestations of Crohn's disease. Am J Dermatopathol. 2011;33:588-593.
23. Vaid RM, Cohen BA. Cutaneous Crohn's disease in the pediatric population. Pediatr Dermatol. 2010;27:279-281.
24. Bhaduri S, Jenkinson S, Lewis F. Vulval Crohn's diseaseVa multi-specialty approach. Int J STD AIDS. 2005;16:512-514.
25. Feller ER, Ribaudo S, Jackson ND. Gynecologic aspects of Crohn's disease. Am Fam Physician. 2001;64:1725-1728.
26. Ostlere LS, Langtry JA, Mortimer PS, et al. Hidradenitis suppurativa in Crohn's disease. Br J Dermatol. 1991;125: 384-386.
27. Gee MS, Nimkin K, Hsu M, et al. Prospective evaluation ofMR enterography as the primary imaging modality for pediatric Crohn disease assessment. AJR. 2010;197:224-231.
28. Pai D, Dillman JR, Mahani MG, et al. MRI of vulvar Crohn disease. Pediatr Rad. 2011;41:537-541.
29. Lestre S, Ramos J, Joao A, et al. Cutaneous Crohn's disease presenting as genital warts: successful treatment with adalimumab. Eur J Dermatol. 1920;504-505.
30. Hellers, G, Bergstrand, O, Ewerth, S, et al. Occurrence and outcome after primary treatment of rectal fistulae. Gut. 1980;21:525-527.
31. Champagne BJ, McGee MF. Rectovaginal fistula. Surg Clin North Am. 2010;90:69-82.
32. Akobeng AK. Crohn's disease: current treatment options. Arch Dis Child. 2008;93:787-792.
33. Keighley MR, Allan RN. Current status and influence of operation on perianal Crohn's disease. Int J Colorectal Dis. 1986;1:104-107.
34. Buchman P, Keighley MR, Allan RN, et al. Natural history of perianal Crohn's disease. Ten year follow-up: a plea for conservatism. Am J Surg. 1980;140:42-644.
35. Steele SR. Operative management of Crohn's disease of the colon including anorectal diseases. Surg Clin North Am. 2007;87:611-631.
36. Nelson RL, Abcarian H, Davis FG, et al. Prevalence of benign anorectal disease in randomly selected population. Dis Colon Rectum. 1995;38:341-344.
37. Ziech M, Felt-Bersma R, Stoker J. Imaging of perianal fistulas. Clin Gastroenterol Hepatol. 2009;7:1037-1745.
38. Horsthuis K, Lavini C, Bipat S, et al. Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity. Radiology. 2009;251:380-387.
39. Lewis RT, Maron DJ. Anorectal Crohn's disease. Surg Clin North Am. 2010;90:83-97.
40. Dejaco, C, Harrer M, Waldhoer, T, et al. Antibiotics and azathioprine for the treatment of perianal fissures in Crohn's disease. Aliment Pharmacol Ther. 2003;12:1113-1120.
41. Present DH, Rutgeerts P, Targan SR, et al. Infliximab for the treatment of fistulas in the patients with Crohn's disease. N Eng J Med. 1999;361:2066-2078.
42. Hull TL, Fazio V. Surgical approaches to low anovaginal fistula in Crohn's disease. Am J Surg. 1997;173:95-98.
43. Sandborn WJ, Fazio V, Feagan BG, et al. AGA technical review on perianal Crohn's disease. Gastroenterology. 2003;125:1508-1530.
44. Fleshner PR, Schoetz DJ Jr, Roberts W, et al. Anal fissure in Crohn's disease: a plea for aggressive management. Dis Colon Rectum. 1995;38:1137-1143.
45. Venkatesh KS, Ramamujam PS, Larson DM, et al. Anorectal complications of vaginal delivery. Dis Colon Rectum. 1989; 32:1039-1041.
46. Kuhlman JE, Fishman EK. CT evaluation of enterovaginal and vesicovaginal fistulas. J Comput Assist Tomogr. 1990;14: 390-394.
47. Giordano P, Drew PJ, Taylor, D, et al. Vaginographyinvestigation of choice for clinically suspected vaginal fistulas. Dis Colon Rectum. 1996;39:568-572.
48. Bird D, Taylor D, Lee P. Vaginography: the investigation of choice for vaginal fistulae? Aust N Z J Surg. 1993;63:894-896.
49. Dwarkasing S, Hussain SM, Hop WC, et al. Anovaginal fistulas: evaluation with enoanal MR imaging. Radiology. 2004;231:123-128.
50. Parsi MA, Lashner BA, Achkar JP, et al. Type of fistula determines response to infliximab in patients with fistulous Crohn's disease. Am J Gastroenterol. 2004;127:772-729.
51. Amankwah YA, Haefner HK, Brincat CA. Management of vulvovaginal strictures/shortened vagina. Clin Obstet Gynecol. 2010;53:125-133.
52. Chu M, Crist H, Zaino RJ. Adenocarcinoma arising in a rectovaginal fistula in Crohn disease. Int J Gynecol Path. 2010;29:497-500.
53. Moore-Maxwell CA, Robboy SJ. Mucinous adenocarcinoma arising in rectovaginal fistulas associated with Crohn's disease. Gynecol Oncol. 2004;93:266-268.
54. Kane S. Urogenital complication of Crohn's disease. Am J Gastroenterol. 2006;101:s640-s643.
55. Manganiotis AN, Banner MP, Malkowicz SB. Urologic complications of Crohn's disease. Surg Clin North Am. 2001;81: 197-215.
56. Solem CA, Loftus EV Jr, Tremaine WJ, et al. Fistulas to the urinary system in Crohn's disease: clinical features and outcomes. Am J Gastroenterol. 2002;97:2300-2305.
57. Ishii G, Nakajima K, Tanaka N, et al. Clinical evaluation of urolithiasis in Crohn's disease. In J Urol. 2009;16:477-480.
58. Kane S, Khatibi B, Reddy D. Higher incidence of abnormal Pap smears in women with inflammatory bowel disease. Am J Gastroenterol. 2008;103:631-636.
59. Hutfless S, Fireman B, Kane S, et al. Screening differences and risk of cervical cancer in inflammatory bowel disease. Aliment Pharmacol Ther. 2008;28:598-605.
60. Singh H, Demers AA, Nugent Z. Risk of cervical abnormalities in women with inflammatory bowel disease: a populationbased nested case-control study. Gastroenterology. 2009; 136:451-458.
61. Lees CW, Critchley J, Chee N, et al. Lack of association between cervical dysplasia and IBD: a large case-control study. Inflamm Bowel Dis. 2009;15:1621-1629.
62. Savoye G, Lerebours E. Abnormal Pap smears in women with Crohn's disease: is there a role for defensin deficiency? Am J Gastroenterol. 2008;103:1046-1047.
63. Long MD, Porter CQ, Sandler RS, et al. Suboptimal rates of cervical testing among women with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2008;7:549-553.
64. National Center for Health Statistics. Health, United States, 2011. Table 91. Available at: http://www.cdc.gov/nchs/data/hus/2011/091.pdf. June 25, 2012.
65. US Department of Health and Human Services. Healthy People 2020. Available at: http://www.healthypeople.gov/2020/topicsobjectives2020/pdfs/ HP2020objectives.pdf. June 25, 2012.
66. Greyewood RC, Fine SD, Borum ML. Appropriate cervical cancer screening remains essential: the case of women with inflammatory bowel disease. Am J Obstet Gynecol. 2012 Feb;206(2):e6-7. doi: 10.1016/j.ajog.2011.10.007. Epub 2011 Oct 15.
67. Pedersen N, Duricova D, Elkjaer M, et al. Risk of extraintestinal cancer in inflammatory bowel disease: metaanalysis of population-based cohort studies. Am J Gastroenterol. 2010;105:1480-1487.
68. Weber AM, Ziegler C, Belinson JL, et al. Gynecologic history of women with inflammatory bowel disease. Obstet Gynecol. 1995;86:843-847.
69. Watson JD. The gynecological manifestations of Crohn's disease. Wis Med J. 1995;94:203-204.
70. Parlak E, Dagli U, Alkim C, et al. Pattern of gastrointestinal and psychosomatic symptoms across the menstrual cycle in women with inflammatory bowel disease. Turk J Gastroenterol. 2003;14:250-256.
71. Tilg H, Moschen AR, Kaser A, et al. Gut, inflammation and osteoporosis: basic and clinical concepts. Gut. 2008;57: 684-694.
72. Ali T, Lam D, Bronze MS, et al. Osteoporosis in inflammatory bowel disease. Am J Med. 2009;122:599-604.
73. Harpavat M, Greenspan SL, O'Brien C, et al. Altered bone mass in children at diagnosis of Crohn disease: a pilot study. J Pediatr Gastroenterol Nutr. 2005;40:295-300.
74. Mauro M, Radovic V, Armstrong D. Improvement of lumber bone mass after infliximab therapy for Crohn's disease patients. Can J Gastroenterol. 2007;21:637-642.
75. Kane SV, Reddy D. Hormonal replacement therapy after menopause is protective of disease activity in women with inflammatory bowel disease. Am J Gastroenterol. 2008;103: 1193-1196.
76. Heetun ZS, Byrnes C, Neary P, et al. Review article: reproduction in the patient with inflammatory bowel disease. Aliment Pharmacol Ther. 2007;26:513-533.
77. Marri SR, Ahn C, Buchman AL. Voluntary childlessness is increased in women with inflammatory bowel disease. Inflamm Bowel Dis. 2007;591-599.
78. Mountfield R, Bampton P, Prosser R, et al. Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions. Inflamm Bowel Dis. 2009;15:720-725.
79. Arkuran C, McComb P. Crohn's disease and tubal infertility: the effect of adhesion formation. Clin Exp Obstet Gynecol. 2000;27:12-13.
80. Waljee A,Waljee J,Morris AM, et al. Threefold increase risk of infertility: a meta-analysis of infertility after ileal pouch and anal anastomosis in ulcerative colitis. Gut. 2007;55: 1575-1580.
81. Dubinsky M, Abraham B, Mahadevan U. Management of the pregnant IBD patient. Inflamm Bowel Dis. 2008;14: 1736-1750.
82. Ilnyckyj A. Surgical treatment of inflammatory bowel diseases and pregnancy. Best Pract Res Clin Gastroenterol. 2007;21: 819-834.
83. Dignass AU, Hartmann F, Sturm A, et al. Management of inflammatory bowel diseases. Dig Dis. 2009;27:341-346.
84. De Vroey B, Schapira M. Pregnancy and inflammatory bowel diseases from conception. Acta Gastroenterol Belg. 2009; 72:238-244.
85. Cornish J, Tan E, Teare J, et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut. 2007;56:830-837.
86. Cassina M, Fabris L, Okolicsanyi L, et al. Therapy of inflammatory bowel diseases in pregnancy and lactation. Expert Opin Drug Saf. 2009;8:695-707.
87. Faculty of Family Planning & Reproductive Health Care Clinical Effectiveness Unit. Contraceptive choices for women with inflammatory bowel disease. J Fam Plan Reprod Health Care. 2003;29:127-135.
88. Okoro NI, Kane SV. Gender-related issues in the female inflammatory bowel disease patient. Expert Rev Gastroenterol Hepatol. 2009;3:145-154.
89. Zapata LB, Paulen ME, Cansino C, et al. Contraceptive use among women with inflammatory bowel disease: a systematic review. Contraception. 2010;82:72-85.
90. Weisberg E. Contraceptive options for women in selected circumstances. Best Pract Res Clin Obstet Gynaecol. 2010; 24:593-604.
91. Rodriguez LA, Gonzalez-Perez A, Johansson S, et al. Risk factors for inflammatory bowel disease in the general population. Aliment Pharmacol Ther. 2005;22:309-315.
92. Cornish JA, Tan E, Simillis C, et al. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta analysis. Am J Gastroenterol. 2008;103: 2394-2400.
93. Jamieson DJ, Hillis SD, Duerr A, et al. Complications of interval laparoscopic tubal sterilization: findings from the United States collaborative review of sterilization. Obstet Gynecol. 2000;96:997-1002.
94. Mikocka-Walus AA. Treatment of psychological co-morbidities in common gastrointestinal and hepatologic disorders. World J Gastrointest Pharmacol Ther. 2010;6:64-71.
95. Muller KR, Prosser R, Bampton P, et al. Female gender and surgery impair relationships, body image and sexuality in inflammatory bowel disease: patient perceptions. Inflamm Bowel Dis. 2010;16:657-663.
96. Moleski SM, Choydhary C. Considerations for women with IBD. Gastroenterol Clin North Am. 2011;40:387-398.
97. Wikland M, Jansson I, Asztely M, et al. Gynaecological problems related to anatomical changes after conventional proctocolectomy and ileostomy. In J Colorectal Dis. 1990; 5:49-52.
98. Loftus EV Jr, Guerin A, Yu AP, et al. Increased risks of developing anxiety and depression in young patients with Crohn's disease. Am J Gastroenterol. 2011;106:1670-1677.
99. Timmer A, Kemptner D, Bauer A, et al. Determinants of female sexual function in inflammatory bowel disease: a survey based cross-sectional analysis. BMC Gastroeterol. 2008; 8:45-55.
100. Kane S, Sable K, Hanauer S. The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study. Am J Gastroenterology. 1998;93:1867-1872.